These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8753896)

  • 1. [The use of high-dose chemotherapy in the treatment of breast cancer].
    Espinosa E; Zamora P; González Barón M
    Med Clin (Barc); 1996 Jun; 107(2):56-8. PubMed ID: 8753896
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose density in breast cancer: a simple message?
    Lin NU; Gelman R; Winer EP
    J Natl Cancer Inst; 2005 Dec; 97(23):1712-4. PubMed ID: 16333021
    [No Abstract]   [Full Text] [Related]  

  • 3. [High dosage chemotherapy and peripheral blood stem cell transplantation in breast carcinoma].
    Jentsch-Ullrich K; Höffken HG; Franke A
    Zentralbl Chir; 1998; 123 Suppl 5():162-4. PubMed ID: 10063605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma RS
    J Natl Cancer Inst; 2008 May; 100(9):618-9. PubMed ID: 18445811
    [No Abstract]   [Full Text] [Related]  

  • 5. [High dose chemotherapy and stem cell transplant in patients with operable breast cancer and a poor prognosis; not indicated for the time being].
    Slee PH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(1):9-12. PubMed ID: 14750448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
    Brockstein BE; Williams SF
    Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trials, clinical use, and hope: what relationship?
    Rettig RA; Jacobson PD; Farquhar CM; Aubry WM
    J Clin Oncol; 2008 May; 26(13):2223-4. PubMed ID: 18445852
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results.
    Cagnoni PJ; Shpall EJ; Bearman SI; Ross M; Jones RB
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S26-9. PubMed ID: 8899166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of breast carcinoma].
    Dittrich C
    Wien Med Wochenschr; 2000; 150(4):72-86. PubMed ID: 10829307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of dose-dense chemotherapy in the management of breast cancer.
    Norton L
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):36-7. PubMed ID: 16562368
    [No Abstract]   [Full Text] [Related]  

  • 12. [Place of high-dose therapy in breast cancer. Austrotransplant consensus conference 1999].
    Greinix H
    Wien Klin Wochenschr; 2000 Jul; 112(13):601-3. PubMed ID: 11001746
    [No Abstract]   [Full Text] [Related]  

  • 13. Bevacizumab: new indication. Metastatic breast cancer: many adverse effects.
    Prescrire Int; 2008 Dec; 17(98):236. PubMed ID: 19422148
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
    Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
    J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dose chemotherapy with hematopoietic stem-cell support in breast cancer].
    Viens P; Maraninchi D
    Bull Cancer; 2001 Sep; 88(9):835-41. PubMed ID: 11604355
    [No Abstract]   [Full Text] [Related]  

  • 16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of cytostatic drug dose in adjuvant chemotherapy of breast carcinoma].
    Thomssen C
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M102-5. PubMed ID: 8964443
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose therapy in breast cancer: out of favor but not out of promise.
    Glück S; Stewart D
    Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapatinib: new drug. For some women with metastatic breast cancer.
    Prescrire Int; 2009 Feb; 18(99):9. PubMed ID: 19382400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.